4Ju JH,Cho ML,Jhun JY,et al. Oral administration of type-Ⅱ collagen wuppresses IL-17-associated RANKL expression of CD4^+ T cells in collagen-induced arthritis [ J ]. Immunol Lett, 2008, 117 (1) :16-25.
5Riechelmann H. Immunotherapy with allergen extracts for allergic rhinitis [ J]. HNO ,2005,53 (6) :517-530.
6Wang D, Christopher ME, Nagata LP,et al. Intranasal immunization with liposome-encapsulated plasmid DNA encoding.influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses [ J ]. J Clln Virol,2004,31 ( Suppl 1 ) :99 -106.
7Van Wilsem E J, van Hoogstraten, Breve J, et al. Dendrifie cell of the oral mucosa and induction of oral tolerance [ J ]. Immunology, 1994,83 ( 1 ) : 128-132.
8Takabayashi K, Libet L, Chisholm D,et al. Intranasal immunothera- py is more effective than intradermal immunotherapy for the induc- tion of airway allergen tolerance in Th2-sensitized mice [ J ]. J Immunol.2003.170 ( 7 ):3898-3905.
9Ma YB, Allen GM, Peng ZK. A potential immunotherapy approach: Mucosal immunization with an IL-13 peptide-based virus-like particle vaccine in a mouse asthma model [ J ]. Vaccine, 2007,25 (47) :8091-8099.
10Ippoliti F, De Santis W, Volterrani A, et al. Immunomodulation during sublingual therapy in allergic children [ J ]. Pediatr Allergy Immunol,2003,14 ( 3 ) :216-221.